Branle, Fabrice

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Soria, J.-C., Tan, D. S. W., Chiari, R., Wu, Y.-L., Paz-Ares, L., Wolf, J., Geater, S. L., Orlov, S., Cortinovis, D., Yu, C.-J., et al. (2017) · The Lancet

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 1,151

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

Mascaux, C., Paesmans, M., Berghmans, T., Branle, F., Lafitte, J. J., Lemaı̂tre, F., Meert, A. P., Vermylen, P., & Sculier, J. P. (2000) · Lung Cancer

Lung Cancer Research StudiesLung Cancer Diagnosis and Treatment

Cited by 270

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature

Sculier, J. P., Ghisdal, L., Berghmans, T., Branle, F., Lafitte, J. J., Vallot, F., Meert, A. P., Lemaitre, F., Steels, E., Burniat, A., et al. (2001) · British Journal of Cancer

Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations

Cited by 37